Literature DB >> 21906254

The emerging role of the TIM molecules in transplantation.

M Y Yeung1, M McGrath, N Najafian.   

Abstract

Since their discovery in 2001, the T-cell immunoglobulin mucin (TIM) family members have been shown to play important roles in the regulation of immune responses. The TIM family comprises of eight genes in the mouse, three of which are conserved in humans (TIM-1, TIM-3 and TIM-4). Initially, TIM-1 and TIM-3 were thought to be expressed solely on T cells. However, emerging data suggest a much broader expression pattern where their presence on APCs confers differing functions, including the ability to mediate phagocytosis. In contrast, TIM-4 is exclusively expressed on APCs. Together, the TIM molecules provide a functional repertoire for determining the fate of T-cell activation and differentiation. To date, much of the knowledge about the TIM family members has been garnered from the models of asthma, allergy and autoimmunity. More recently, data from experimental models of transplantation demonstrate that TIM family members also have a key role in alloimmunity. This review will serve to highlight the emerging data regarding this unique family of molecules and to identify their potential in transplantation tolerance. ©Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906254      PMCID: PMC3205957          DOI: 10.1111/j.1600-6143.2011.03727.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  51 in total

1.  T cell Ig and mucin 1 (TIM-1) is expressed on in vivo-activated T cells and provides a costimulatory signal for T cell activation.

Authors:  Anjali J de Souza; Timothy B Oriss; Katherine J O'malley; Anuradha Ray; Lawrence P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

2.  TIM-1 induces T cell activation and inhibits the development of peripheral tolerance.

Authors:  Sarah E Umetsu; Wan-Ling Lee; Jennifer J McIntire; Laura Downey; Bharati Sanjanwala; Omid Akbari; Gerald J Berry; Haruo Nagumo; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Nat Immunol       Date:  2005-03-27       Impact factor: 25.606

3.  Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity.

Authors:  Sylvia Frisancho-Kiss; Jennifer F Nyland; Sarah E Davis; Masheka A Barrett; Shannon J L Gatewood; Dolores B Njoku; Daniela Cihakova; Ellen K Silbergeld; Noel R Rose; DeLisa Fairweather
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

4.  Epitope-dependent effect of anti-murine TIM-1 monoclonal antibodies on T cell activity and lung immune responses.

Authors:  Irene D Sizing; Véronique Bailly; Patricia McCoon; Wenjie Chang; Sambasiva Rao; Lourdes Pablo; Rachel Rennard; Meghan Walsh; Zhifang Li; Mohammad Zafari; Max Dobles; Leticia Tarilonte; Steven Miklasz; Gerard Majeau; Kevin Godbout; Martin L Scott; Paul D Rennert
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 5.  The TIM gene family regulates autoimmune and allergic diseases.

Authors:  Jennifer Hartt Meyers; Catherine A Sabatos; Sumone Chakravarti; Vijay K Kuchroo
Journal:  Trends Mol Med       Date:  2005-08       Impact factor: 11.951

6.  A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9.

Authors:  Philipp S van de Weyer; Michael Muehlfeit; Christoph Klose; Joseph V Bonventre; Gerd Walz; E Wolfgang Kuehn
Journal:  Biochem Biophys Res Commun       Date:  2006-10-23       Impact factor: 3.575

7.  Human TIM-1 associates with the TCR complex and up-regulates T cell activation signals.

Authors:  Lauri L Binné; Martin L Scott; Paul D Rennert
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

8.  The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.

Authors:  Chen Zhu; Ana C Anderson; Anna Schubart; Huabao Xiong; Jaime Imitola; Samia J Khoury; Xin Xiao Zheng; Terry B Strom; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2005-11-13       Impact factor: 25.606

9.  Tim-3 expression in human kidney allografts.

Authors:  Viviane C Ponciano; Paulo G Renesto; Eliana Nogueira; Erika B Rangel; Marcos A Cenedeze; Marcello F Franco; Niels O S Câmara; Alvaro Pacheco-Silva
Journal:  Transpl Immunol       Date:  2006-12-06       Impact factor: 1.708

10.  T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis.

Authors:  Mohsen Khademi; Zsolt Illés; Alexander W Gielen; Monica Marta; Naruhiko Takazawa; Claire Baecher-Allan; Lou Brundin; Jan Hannerz; Claes Martin; Robert A Harris; David A Hafler; Vijay K Kuchroo; Tomas Olsson; Fredrik Piehl; Erik Wallström
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

View more
  19 in total

1.  Stimulation of Camel Polyclonal Antibody against Human T cell Immunoglobulin and Mucin 3.

Authors:  Vida Homayouni; Hossein Khanahmad; Mazdak Ganjalikhani-Hakemi; Mahdi Behdani; Pouria Ghasemi; Abbas Rezaei
Journal:  Iran J Biotechnol       Date:  2017-09-27       Impact factor: 1.671

2.  [Effect of inhibiting TIM-4 function in Kupffer cells on liver graft rejection in mice].

Authors:  Xue-Qiang Li; Xu-Hong Li; Shi-Gang Duan; Xue-Song Xu; Yi-Ming Liu; Jin-Zheng Li; Jian-Ping Gong; Hao Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

3.  TIM4 Regulates the Anti-Islet Th2 Alloimmune Response.

Authors:  Andrea Vergani; Francesca Gatti; Kang M Lee; Francesca D'Addio; Sara Tezza; Melissa Chin; Roberto Bassi; Ze Tian; Erxi Wu; Paola Maffi; Moufida Ben Nasr; James I Kim; Antonio Secchi; James F Markmann; David M Rothstein; Laurence A Turka; Mohamed H Sayegh; Paolo Fiorina
Journal:  Cell Transplant       Date:  2014-03-07       Impact factor: 4.064

4.  Small interfering RNA targeting T-cell Ig mucin-3 decreases allergic airway inflammation and hyperresponsiveness.

Authors:  Xiao-Xia Lu; Karen S McCoy; Jia-Li Xu; Wei-Kun Hu; He-Bin Chen
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

5.  Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Authors:  Yuanxing Liu; Haofeng Ji; Yu Zhang; Xiuda Shen; Feng Gao; Xiangyi He; Gabriella A Li; Ronald W Busuttil; Vijay K Kuchroo; Jerzy W Kupiec-Weglinski
Journal:  J Hepatol       Date:  2014-10-31       Impact factor: 25.083

Review 6.  Rejection and regulation: a tight balance.

Authors:  Isa F Ashoor; Nader Najafian
Journal:  Curr Opin Organ Transplant       Date:  2012-02       Impact factor: 2.640

7.  A bioinformatics approach identifies signal transducer and activator of transcription-3 and checkpoint kinase 1 as upstream regulators of kidney injury molecule-1 after kidney injury.

Authors:  Amrendra Kumar Ajay; Tae-Min Kim; Victoria Ramirez-Gonzalez; Peter J Park; David A Frank; Vishal S Vaidya
Journal:  J Am Soc Nephrol       Date:  2013-10-24       Impact factor: 10.121

8.  Negative CD4 + TIM-3 signaling confers resistance against cold preservation damage in mouse liver transplantation.

Authors:  Yuanxing Liu; Haofeng Ji; Yu Zhang; Xiu-da Shen; Feng Gao; Terry T Nguyen; Xuanming Shang; Nayun Lee; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Am J Transplant       Date:  2015-02-12       Impact factor: 8.086

Review 9.  T Cell Cosignaling Molecules in Transplantation.

Authors:  Mandy L Ford
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.

Authors:  Sarah Y Lee; Joan M Goverman
Journal:  J Immunol       Date:  2013-04-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.